**Core tip:** Gut microflora has been found to associate with promotion of health and occurrence and development of different gastrointestinal/non-gastrointestinal disease. Some traditional Chinese drugs exert effects on diseases by regulating the equilibrium of intestinal microflora. In the present study, we described gut microbial diversity in functional dyspepsia with liver depression-spleen deficiency syndrome in rat models and the effect of Xiaoyaosan intervention.

INTRODUCTION
============

Functional dyspepsia (FD) is a common gastrointestinal disorder\[[@B1]\]. FD is not life-threatening but adversely impacts the patient's quality of life. The pathogenesis of FD is uncertain because of complicated multiple factors. Clinical observation has shown that patients with FD suffer from obvious gastrointestinal motility obstacles, visceral hypersensitivity, *Helicobacter pylori* infection, neuropsychological factors and so on\[[@B2]\]. The occurrence and development of FD is closely related with mood disorders, such as anxiety and depression. Traditional Chinese Medicine (TCM) holds that gastrointestinal function abatement is usually due to spleen deficiency (pixu) and mood disorders with associated liver depression (ganyu). Thus, liver depression-spleen deficiency is regarded as one of the main pathogenesis of FD. In all syndrome types, FD with liver depression-spleen deficiency syndrome is the most common FD in traditional Chinese medical syndrome typing\[[@B3]\].

Xiaoyaosan (XYS) is a well-known Chinese herbal formula and is prescribed to sooth liver, tonify spleen, and nourish blood\[[@B4],[@B5]\]. The Song Dynasty (960-1127 AD) book of "Taiping Huimin Heji Jufang" recorded that XYS comprises the following eight Chinese herbs: Bupleurum root, Chinese angelica root, white peony root, Perenniporia, bighead Atractylodes rhizome, roasted ginger, prepared licorice root, menthol and peppermint. It has long been used for the treatment of FD associated with the syndrome of "liver depression" and "spleen deficiency" in China.

Gastrointestinal microflora plays an important role in the host's life activities\[[@B6],[@B7]\]. When the host's balance of microflora in the gastrointestinal tract is disrupted, the host may become ill. In recent years, the gastrointestinal microflora has been shown to be associated with promotion of health and occurrence and development of different gastrointestinal/non-gastrointestinal diseases\[[@B8],[@B9]\]. Therefore, more experimental research has focused on the relationship between disease and gastrointestinal microflora. Besides, research has shown that some traditional Chinese drugs exert their effects on disease by regulating the equilibrium of intestinal microflora\[[@B10],[@B11]\]. Many molecular biology techniques have been used to illustrate gut microbial diversity, including denaturing/temperature gradient gel electrophoresis, terminal restriction fragment length polymorphism, and high-throughput sequencing\[[@B12]\]. High-throughput sequencing has the advantage of providing more and detailed information on microbial diversity with high accuracy, and thus has been widely used in the study of gut microbial diversity. Here, we used the Illumina sequencing to analyze gut microbial diversity of FD. The goal of the current study was to describe gut microbial diversity on FD with liver depression-spleen deficiency syndrome in a rat model and to assess the effect of XYS on microflora.

MATERIALS AND METHODS
=====================

Establishment and validation of rat models
------------------------------------------

Male Sprague-Dawley rats of clean grade were supplied by the Experimental Animal Center of Dalian Medical University, Dalian, China. Rats were kept at a temperature of 23 ± 2 °C and a relative humidity of 55% ± 2% on a 12 h light-dark cycle for 7 d before experimentations. Rats were randomly divided into three groups: normal group (FD1), FD with liver depression-spleen deficiency syndrome group (FD2) and XYS-treated group (FD3). The FD with liver depression-spleen deficiency syndrome rat model was established by including classic chronic mild unpredictable stimulation (bondage, swim-induced fatigue, electrical stimulation, fasting and concussion) every day\[[@B13]\]. The normal and FD model groups were given normal saline intragastrically before initiating stimulation. The XYS group was given XYS intragastrically 1 h before initiating stimulation. The dose of XYS was 15.3 g/kg per day (gavage volume 2 mL).

The models were assessed by state of the rat, weight, sucrose test result and open-field test result. All the procedures of animal experiments were approved by the local Animal Care Committee and in accordance with the Guide for the Care and Use of Laboratory Animals published by the Science and Technology Commission of P.R.C. (STCC Publication No. 2, revised 1988).

Sample collection and DNA extraction
------------------------------------

Stool samples were collected from rats of FD1, FD2 and FD3 groups. The stools were suspended, respectively, in TE buffer with lysozyme. Total bacterial DNAs were extracted using the Stool DNA Isolation Kit (FORE GENE, China) according to the manufacturer's instruction. The total DNAs were determined using electrophoresis on 1% agarose gel containing ethidium bromide. The concentration of DNAs was measured using NanoVue plus (GE, United States).

V4 region of the 16S rDNA PCR amplification
-------------------------------------------

The variable V4 region of 16S rRNA was amplified by PCR using the following barcode primers: upstream primer 515F (5′-GTGCCAGCMGCCGCGGTAA-3′) and downstream primer 806R (5′-GGACTACHVGGGTWTCT AAT-3′). The PCR reaction mixture contained 12.5 μL of Phusion Master Mix (Phusion^®^ High-Fidelity PCR Master Mix with GC Buffer; New England Biolabs, United States), 1 μL of template DNA, 1.25 μL of 10 μmol primer 515F, 1.25 μL of 10 μmol primer 806R and 10 μL of double-distilled H~2~O. The amplification of PCR was performed as follows: 98 °C for 30 s; 30 cycles of 98 °C for 10 s, 54 °C for 30 s, and 72 °C for 30 s; and 72 °C for 7 min. The amplified products were identified by electrophoresis on a 2% agarose gel containing ethidium bromide. The PCR products were purified using the QIAquick Gel Extraction Kit (Qiagen, Germany).

Sequencing PCR amplicons of 16S rDNA
------------------------------------

Library construction was performed using the TruSeq^®^ PCR-Free DNA Sample Preparation Kit and quantified by Qubit and Q-PCR. After library accreditation, purified PCR products of 16S rDNA were sequenced using HiSeq2500 sequencer PE250. Sequencing work was performed in collaboration with Novogene Bioinformatics Technology Co., Ltd (Beijing, China).

Animal care and use statement
-----------------------------

The animal protocol was designed to minimize pain or discomfort to the animals. The animals were acclimatized to laboratory conditions (23 ± 2 °C, 12 h/12 h light/dark, 55% ± 2% humidity, *ad libitum* access to food and water) for 1 wk prior to experimentation. All animals were euthanized by ethyl ether for tissue collection.

Statistical analysis
--------------------

After amputation of the barcode and primer sequences, Raw Tags were obtained by joining reads of each sample using FLASH (V1.2.7, <http://ccb.jhu.edu/software/FLASH/>)\[[@B14]\]. Clean Tags were obtained through the strict filtering process\[[@B15]\]. Effective Tags of all samples were clustered using Uparse software (Uparse v7.0.1001, <http://drive5.com/uparse/>)\[[@B16]\]. Operational Taxonomic Units (OTUs) were defined by clustering 97% identity sequences. Based on the principles of the algorithm, the highest frequency OTUs were screened as the representative OTUs. The microbiomes species at phylum level were annotated by analyzing the representative OTUs with RDP Classifier (version 2.2, <http://sourceforge.net/projects/rdp-classifier/>) method\[[@B17]\] and GreenGene database (<http://greengenes.lbl.gov/cgi-bin/nph-index.cgi>)\[[@B18]\]. The phylogenetic relationships of representative OTUs were identified by multiple sequence alignment using PyNAST software (version 1.2)\[[@B19]\] and "Core Set" of GreenGene database.

RESULTS
=======

Model validation
----------------

The FD with liver depression-spleen deficiency syndrome rat model was established successfully using chronic mild unpredictable stimulation. Compared with the good mental state of the normal group rats, the model group rats were restless and exhibited high alertness. The fur of the model group rats was slightly rough. It was difficult for the model group rats to grasp. The weight of the model group rats significantly decreased, compared to that of the normal group rats (Table [1](#T1){ref-type="table"}). The saccharine preference index of the model group rats was significantly lower than that of the normal group rats (Figure [1](#F1){ref-type="fig"}). At the end of the modeling process, the numbers of crossed-grids, standing and grooming times were calculated. There were significant differences between the model group and the normal group in all these parameters (Table [2](#T2){ref-type="table"}).

###### 

Rat weight (g, mean ± SE)

        **Model before**   **Model after**
  ----- ------------------ -----------------------------------------------
  FD1   220.33 ± 1.20      264.17 ± 1.17
  FD2   220.50 ± 1.06      236.00 ± 1.17[a](#T1FN1){ref-type="table-fn"}

Normal group: FD1; Model group: FD2.

*P* \< 0.01 *vs* the normal group.

![Saccharine preference index of the normal group (FD1) and the model group (FD2). The data are presented as mean ± SE. ^a^*P* \< 0.01 *vs* the normal group.](WJG-23-810-g001){#F1}

###### 

Open-field test (mean ± SE)

                        **Model before**   **Model after**
  --------------------- ------------------ ---------------------------------------------
  Stand-up times                           
  FD1                   21.83 ± 0.95       18 ± 1.00
  FD2                   22.00 ± 0.89       3.00 ± 0.78[a](#T2FN1){ref-type="table-fn"}
  Number of crossings                      
  FD1                   55.33 ± 1.31       50.67 ± 0.80
  FD2                   54.83 ± 2.23       8.33 ± 0.92[a](#T2FN1){ref-type="table-fn"}
  Number of cleanings                      
  FD1                   9.83 ± 0.60        8.83 ± 0.31
  FD2                   9.83 ± 0.48        2.17 ± 0.40[a](#T2FN1){ref-type="table-fn"}

Normal group: FD1; Model group: FD2.

*P* \< 0.01 *vs* the normal group.

Identification of PCR products of the V4 region of 16S rDNA
-----------------------------------------------------------

Amplified PCR products were examined by agarose gel electrophoresis (Figure [2](#F2){ref-type="fig"}). The V4 region PCR products of 16S rDNA were obtained.

![Agarose gel electrophoresis of PCR products of the V4 region of 16S rDNA. Normal group: FD (1.1-1.3); Model group: FD (2.1-2.3); Xiaoyaosan group: FD (3.1-3.3). FD: Functional dyspepsia.](WJG-23-810-g002){#F2}

Sequencing and quality control
------------------------------

The number of Effective Tags and OTUs observed after sequencing are shown in Figure [3](#F3){ref-type="fig"}. The Effective Tags of all samples were enough to cluster to OTUs. The representative OTUs were used for annotating.

![Statistical graph of Tags and Operational Taxonomic Unit clustering. Normal group: FD (1.1-1.3); Model group: FD (2.1-2.3); Xiaoyaosan group: FD (3.1-3.3). Total Tags: Effective Tags; Unique Tags: Uneffective Tags; Taxon Tags: Annotated Tags for OTUs; Unclassified Tags: Unannotated Tags. OTUs: Operational Taxonomic Units; FD: Functional dyspepsia.](WJG-23-810-g003){#F3}

Phylum level taxonomic distribution of microbiomes
--------------------------------------------------

The microbiomes contained 20 phyla and 156 genera in all rat stool samples (Figure [4](#F4){ref-type="fig"}). The composition microbiome of all samples was similar at the phyla level. *Firmicutes*, *Bacteroidetes*, *Proteobacteria*, *Cyanobacteria* and *Tenericutes* were the most abundant taxonomic groups. The relative abundance of *Firmicutes, Proteobacteria* and *Cyanobacteria* in the FD model group was individually higher than in the normal group. On the contrary, the relative abundance of *Bacteroidetes* in the FD model group was lower than observed in the normal group. After XYS treatment, the relative abundance of all altered phyla readjusted to levels comparable to those observed in the normal rats.

![Relative abundance of the microbiomes at the phylum level. Normal group: FD1; Model group: FD2; Xiaoyaosan group: FD3. FD: Functional dyspepsia.](WJG-23-810-g004){#F4}

Species abundance clustering heat map at the phylum level
---------------------------------------------------------

The abundance clustering heat map of phyla was consistent with results of phylum level taxonomic distribution (Figure [5](#F5){ref-type="fig"}).

![Heat map of species abundance clustering at the phylum level. Normal group: FD1; Model group: FD2; Xiaoyaosan group: FD3. FD: Functional dyspepsia.](WJG-23-810-g005){#F5}

DISCUSSION
==========

In this study, we modeled FD with liver depression-spleen deficiency syndrome in rats and observed changes in gut microbial diversity with or without XYS intervention.

FD is a common clinical digestive disease with epigastric discomfort, postprandial full bilge, abdominal bloating, belching, anorexia, nausea, vomiting, heartburn and other symptoms that occur persistently or recurrently\[[@B20]\]. FD with liver depression-spleen deficiency syndrome is one of the most common FD subtypes in TCM. Modern medicinal knowledge has indicated psychiatric factors as the most important etiologic factors. We used unpredictable stimulations to mimic psychiatric stress to induce FD in rats\[[@B21]\]. These stimulations led to successful FD with liver depression-spleen deficiency syndrome through making rats nervous and depressive for a long time.

Some studies have indicated the influence that gut microbial diversity may have on different diseases, including gastrointestinal disease, incretion disease and mental disease\[[@B22]\]. Therefore, understanding the interaction between the microbiota and the host's physiology may facilitate the exploration of new therapeutic targets for certain diseases. FD with liver depression-spleen deficiency syndrome belongs to a kind of gastrointestinal disease caused by psychiatric factors. While XYS was the TCM prescription used for the treatment of FD with liver depression-spleen deficiency syndrome\[[@B23]\], it has become widely accepted in microbial diversity analysis by employing the sequencing technique in this postmetagenomic era.

In our study, the microbiomes of the normal group, the FD model group and the XYS-treated FD group rats were classified at the phylum level. *Firmicutes*, *Bacteroidetes* and *Proteobacteria* were the three most abundant taxonomic groups in all group samples. These groups of microorganisms have, in fact, been indicated as the three predominant phyla in the gut of animals and humans\[[@B24]\]. The experimental groups had similar microbiome distributions but with varied phyla abundances within each microbiome. *Firmicutes* was the most favored microflora and the highest in proportion in the gut of mammals. Many bacteria of the phyla *Firmicutes* can produce butyrate. Butyrate is an important source of energy for colonic epithelial cells\[[@B25]\]. *Bacteroidetes* and *Proteobacteria* were the second and third favored microflora, respectively. Many *Bacteroidetes* are involved in the metabolic processing of polysaccharides, steroids and bile acids, whereas *Proteobacteria* are pathogenic\[[@B26],[@B27]\]. The increased relative abundance of *Firmicutes* and *Proteobacteria* coupled with the decreased relative abundance of *Bacteroidetes* in the FD microbiome as compared with the microbiome of normal rats suggests an association between increased *Proteobacteria* with decreased *Bacteroidetes* and the occurrence of FD with liver depression-spleen deficiency syndrome. Although the relative abundance of *Fusobacteria* was generally low, it indicated a plausible positive association with *Proteobacteria*. *Fusobacteria* is a common resident pathogen in gut mucosa and has been linked to gastrointestinal disease\[[@B28]\]. Upon treatment of FD rats with XYS, the relative abundances of *Firmicutes, Proteobacteria* and *Bacteroidetes* were adjusted to similar levels, as identified in the microbiome of normal rats, with enhanced decrease of *Fusobacteria*. We infer that the therapeutic function of XYS on FD may, at least partly, be due to its ability to restore gut microbial homeostasis. Notwithstanding, further studies are needed to define the molecular factors and downstream mechanisms that are chiefly influenced during the dysbiosis-microbiome restoration activities in FD.

In summary, this study investigated the gut microbial diversity of FD in a rat model and indicated that the microbiome composition of FD with liver depression-spleen deficiency syndrome was significantly different from the normal cohort. Intervention with XYS restored the gut dysbiosis in FD to normalcy. The data thus shed light on a plausible means by which XYS may achieve its therapeutic function in FD.

COMMENTS
========

Background
----------

Functional dyspepsia (FD) with liver depression-spleen deficiency syndrome is not life-threatening but adversely impacts the patient's quality of life. Xiaoyaosan (XYS) is a common Chinese herbal formula and has long been used for the treatment of FD associated with the syndrome of "liver depression" and "spleen deficiency" in China. Gastrointestinal microflora plays an important role in the host's life activities. Descriptions of the gut microbial diversity of FD rat models and those intervened with XYS will facilitate the understanding of FD pathogenesis and clarify the mechanism of XYS.

Research frontiers
------------------

Gastrointestinal microflora has been found to associate with promotion of health and occurrence and development of different gastrointestinal/non -gastrointestinal diseases in recent years. Besides, research has shown that some traditional Chinese drugs exert their effects on disease by regulating the equilibrium of intestinal microflora.

Innovations and breakthroughs
-----------------------------

Gut microbial diversity is related to different diseases, such as gastrointestinal disease, incretion disease and mental disease. Some traditional Chinese drugs exert their effects on disease by regulating the equilibrium of intestinal microflora. There is no report to date on the relationship between gut microbial diversity, FD with liver depression-spleen deficiency syndrome and XYS.

Applications
------------

These data will facilitate the exploration of new therapeutic targets of disease by increasing the understanding of the interaction between the microbiota and the host's physiology. Clarification of the XYS intervention will provide a theoretical basis for promotion and application of Chinese traditional medicine.

Terminology
-----------

Illumina sequencing, also known as next-generation sequencing, describes sequencing of millions of gene fragments by synthesis with reversible terminators.
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